OncoSil Medical Ltd (AU:OSL) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
OncoSil Medical Ltd has achieved a significant milestone with the successful implantation of its OncoSil™ device for pancreatic cancer treatment at Italy’s Instituto Nazionale dei Tumori. This advancement enhances OncoSil’s presence in Europe and signifies progress in providing innovative solutions for challenging cancers. The device, which has received breakthrough designation in multiple regions, is set to transform treatment options for pancreatic cancer patients.
For further insights into AU:OSL stock, check out TipRanks’ Stock Analysis page.